12 Best NASDAQ Penny Stocks to Buy According to Analysts

Page 9 of 11

3. Neumora Therapeutics Inc (NASDAQ:NMRA)

Neumora Therapeutics Inc (NASDAQ:NMRA) is among the best NASDAQ penny stocks to buy according to analysts. Presenting at the Guggenheim Emerging Outlook: Biotech Summit 2026 on February 11, Neumora executives shared additional data from the Phase 1b study of drug candidate NMRA-511. Neumora is developing NMRA-511 as a treatment for agitation in Alzheimer’s disease patients.

At the summit, Neumora President Josh Pinto reiterated positive results from the study and emphasized what that study was designed to show. Notably, the study was meant to estimate effect size rather than statistical significance.

According to Pinto, the effect sizes were met with a favorable safety and tolerability profile. The executives believe this outcome provides a chance to advance to higher dose testing in 2026.

In other related news, on January 12, Leerink Partners launched coverage on Neumora Therapeutics (NASDAQ:NMRA) stock with an Outperform rating and a price target of $8. For this action, the firm pointed to Neumora’s diverse portfolio, noting that several programs have “a good chance of success.”

Based in Watertown, Massachusetts, Neumora Therapeutics Inc (NASDAQ:NMRA) is a clinical-stage biopharmaceutical company. It’s focused on developing treatments for brain diseases, neurodegenerative diseases, and neuropsychiatric disorders.

Page 9 of 11